Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

NCT07068191 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Hepatomegaly
Nonalcoholic Fatty Liver (NAFL)
Nonalcoholic Fatty Liver Disease (NAFLD)
Fatty Liver
Fatty Liver, Alcoholic
Fatty Liver, Nonalcoholic
Fatty Liver Disease

Interventions

COMBINATION_PRODUCT: Dietary supplement "Gepaktiv"
DRUG: UDCA (Ursodeoxycholic acid)
DRUG: Ademetionine

Sponsor

Phenomen Pharma